Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits
Abstract:
A rabbit model of pneumococcal meningitis was used to examine the importance of bactericidal vs. bacteriostatic antimicrobial agents in the therapy of meningitis 112 animals were infected with one of two strains of type III Streptococcus pneumoniae. Both strains were exquisitely sensitive to ampicillin, minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC)<0.125 mug/ml. The activity of chloramphenicol against the two strains varied: strain(1)-MIC 2 mug/ml, MBC 16 mug/ml; strain(2)-MIC 1 mug/ml, MBC 2 mug/ml. Animals were treated with either ampicillin or chloramphenicol in dosages that achieved a peak bactericidal effect in cerebrospinal fluid (CSF) for ampicillin against both strains. Two different dosages were used for chloramphenicol. The first dosage achieved a peak CSF concentration of 4.4+/-1.1 mug/ml that produced a bacteriostatic effect against strain(1) and bactericidal effect against strain(2). The second dosage achieved a bactericidal effect against both strains (mean peak CSF concentration 30.0 mug/ml). All animals were treated intramuscularly three times a day for 5 d. CSF was sampled daily and 3 d after discontinuation of therapy for quantitative bacterial cultures. Results demonstrate that only antimicrobial therapy that achieved a bactericidal effect in CSF was associated with cure. Over 90% of animals treated with one of the bactericidal regimens (i.e., animals in which the bacterial counts in CSF dropped >5 log(10) colony-forming units [cfu]/ ml after 48 h) had sterile CSF after 5 d of treatment. On the other hand, the regimen that achieved bacteriostatic concentrations (CSF drug concentrations between the MIC and MBC) produced a drop of 2.4 log(10) cfu/ml by 48 h; however, none of the animals that survived had sterile CSF after 5 d. These studies clearly demonstrate in a strictly controlled manner that maximally effective antimicrobial therapy of experimental pneumococcal meningitis depends on achieving a bactericidal effect in CSF.
Insights
Bactericidal antimicrobial agents, which kill bacteria, are essential for treating pneumococcal meningitis. Bacteriostatic agents, which inhibit bacterial growth, were ineffective in a rabbit model, highlighting the need for bactericidal therapy in cerebrospinal fluid (CSF).
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Pneumococcal meningitis is a serious infection requiring effective antimicrobial therapy.
- The distinction between bactericidal (bacteria-killing) and bacteriostatic (bacteria-inhibiting) antimicrobial activity is crucial in treating infections.
- Cerebrospinal fluid (CSF) drug concentrations are critical for therapeutic success in meningitis.
Purpose of the Study:
- To evaluate the efficacy of bactericidal versus bacteriostatic antimicrobial agents in a rabbit model of pneumococcal meningitis.
- To determine the impact of drug concentration and bactericidal activity within the CSF on treatment outcomes.
Main Methods:
- A rabbit model was infected with Streptococcus pneumoniae.
- Animals received ampicillin or chloramphenicol, with dosages adjusted to achieve specific bactericidal or bacteriostatic effects in CSF.
- Cerebrospinal fluid (CSF) samples were collected daily and post-treatment for quantitative bacterial cultures.
Main Results:
- Antimicrobial therapy achieving a bactericidal effect in CSF was associated with a cure in over 90% of animals.
- Regimens achieving only bacteriostatic concentrations in CSF resulted in limited bacterial reduction and no sterile CSF post-treatment.
- Ampicillin demonstrated consistent bactericidal activity, while chloramphenicol's activity varied with dosage.
Conclusions:
- Achieving a bactericidal effect within the cerebrospinal fluid (CSF) is essential for the effective treatment of experimental pneumococcal meningitis.
- Bacteriostatic therapy alone is insufficient for sterilizing the CSF and achieving a cure.
- This study underscores the importance of selecting antimicrobial agents and dosages that ensure bactericidal activity at the site of infection.
More Related Videos
09:09Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis II: Pathophysiology
